Study Evaluating PK/PD and Safety of Betrixaban in Pediatric Patients
Status:
Completed
Trial end date:
2019-10-08
Target enrollment:
Participant gender:
Summary
A Phase 1, Open-Label, Single-Dose, Non-Randomized Study to Evaluate Pharmacokinetics,
Pharmacodynamics, and Safety of Betrixaban in Pediatric Patients